Zoliflodacin Granule
NDC Package 75907-374-80

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Zoliflodacin granules is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a granule delivery system. Marketed by Dr. Reddy's Laboratories Inc., this product is identified by NDC 75907-374.

Identification & Billing

NDC Package Code
75907-374-80
Package Description
80 PACKET in 1 CARTON / 3 g in 1 PACKET
Product Code
75907-374
11-Digit Billing Format
75907037480
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zoliflodacin
Non-Proprietary Name
Zoliflodacin
Substance Name
Zoliflodacin
Dosage Form
Granule - A small particle or grain.
Active Ingredient(s)
ZOLIFLODACIN 3 g/3g

Regulatory & Marketing

Labeler Name
Dr. Reddy's Laboratories Inc.
Product Type
Bulk Ingredient
Marketing Category
EXPORT ONLY - A product that is only exported and not marketed in the United States.
Start Marketing Date
02-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75907-374-80 identifies a specific commercial package of 80 packet in 1 carton / 3 g in 1 packet of Zoliflodacin (UNFINISHED drug), a bulk ingredient labeled by Dr. Reddy's Laboratories Inc.. This granule is formulated for use and contains zoliflodacin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Laboratories Inc. on February 01, 2026. The current certification is valid through December 31, 2027.

How is this Dr. Reddy's Laboratories Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75907037480. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75907-374-80
11-Digit CMS (5-4-2)
75907-0374-80

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.